GF Fund Management CO. LTD. Increases Stake in Tempus AI, Inc. (NASDAQ:TEM)

GF Fund Management CO. LTD. lifted its position in Tempus AI, Inc. (NASDAQ:TEM) by 21.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,902 shares of the company’s stock after acquiring an additional 702 shares during the quarter. GF Fund Management CO. LTD.’s holdings in Tempus AI were worth $188,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Bank of New York Mellon Corp bought a new position in Tempus AI in the fourth quarter worth approximately $1,615,000. US Bancorp DE purchased a new stake in shares of Tempus AI during the 4th quarter worth $80,000. Victory Capital Management Inc. bought a new stake in Tempus AI during the fourth quarter valued at about $216,000. Raymond James Financial Inc. purchased a new position in Tempus AI in the fourth quarter valued at about $3,757,000. Finally, Farther Finance Advisors LLC bought a new position in Tempus AI in the fourth quarter worth about $34,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on TEM. Bank of America increased their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research report on Wednesday, June 25th. Needham & Company LLC reissued a “buy” rating and set a $70.00 target price on shares of Tempus AI in a research report on Wednesday, May 7th. Morgan Stanley raised their target price on shares of Tempus AI from $60.00 to $65.00 and gave the company an “overweight” rating in a research note on Friday, May 9th. Piper Sandler lifted their price target on shares of Tempus AI from $55.00 to $70.00 and gave the stock a “neutral” rating in a report on Thursday, May 15th. Finally, Guggenheim increased their price objective on Tempus AI from $65.00 to $75.00 and gave the company a “buy” rating in a report on Monday, June 30th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $63.67.

Tempus AI Price Performance

NASDAQ TEM opened at $60.65 on Friday. The company has a market cap of $10.50 billion and a price-to-earnings ratio of -7.78. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. The stock’s fifty day moving average price is $62.53 and its 200 day moving average price is $54.12. Tempus AI, Inc. has a 1 year low of $30.81 and a 1 year high of $91.45.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.03. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. The business’s revenue was up 75.4% on a year-over-year basis. As a group, equities research analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Erik Phelps sold 51,317 shares of the business’s stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the completion of the transaction, the executive vice president directly owned 97,779 shares in the company, valued at $7,094,844.24. The trade was a 34.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Eric P. Lefkofsky sold 250,000 shares of the business’s stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $70.07, for a total transaction of $17,517,500.00. Following the transaction, the chief executive officer owned 9,357,283 shares of the company’s stock, valued at $655,664,819.81. This represents a 2.60% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 607,522 shares of company stock worth $41,300,238 in the last quarter. 27.60% of the stock is currently owned by corporate insiders.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.